| 1） |
Preliminary report: effect of encainide and flecainide on mortality in a randomized trial of arrhythmia suppression after myocardial infarction. The Cardiac Arrhythmia Suppression Trial (CAST) Investigators. N Engl J Med 1989; 321: 406-412. |
| 2） |
Myerberg RJ, Castellanos A: Cardiac arrest and sudden cardiac death; In Braunwald E (ed): The Heart Disease. Philadelphia, WB Saunders, 1988; p756-789. |
| 3） |
Bayés de Luna A, Coumel P, Leclercq JF: Ambulatory sudden cardiac death: mechanisms of production of fatal arrhythmia on the basis of data from 157 cases. Am Heart J 1989; 117: 151-159. |
| 4） |
豊嶋英明，田辺直仁：心臓性突然死の疫学．村山正博，笠貫 宏編集，心臓性突然死，医学書院，1997; p6-18. |
| 5） |
八木 繁監修，佐藤忠一，杉本恒明，中村芳郎，渡部良夫編集: ホルター心電図記録中の急死例，Excerpta Medica 1991. |
| 6） |
松田直樹，笠貫 宏，野崎 彰，杉本恒明，中川幹子，伊東盛夫ほか：ホルター心電図記録中の突然死例の検討－ホルター心電図研究会アンケート調査にもとづいて－．心電図 1998; 18(suppl 1): 28. |
| 7） |
笠貫 宏：ICDの適応．日本心臓ペーシング・電気生理学会植込み型除細動器調査委員会編集，植込み型除細動器の臨床，医学書院，1998; p15-32. |
| 8） |
Gregoratos G, Cheitlin MD, Conill A, Epstein AE, Fellows C, Ferguson TB, et al: ACC/AHA guidelines for implantation of cardiac pacemakers and antiarrhythmia devices: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Pacemaker Implantation). J Am Coll Cardiol 1998; 31: 1175-1209. |
| 9） |
Gregoratos G, Cheitlin MD, Conill A, Epstein AE, Fellows C, Ferguson TB, et al: ACC/AHA Guidelines for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices: Executive Summary--a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Pacemaker Implantation). Circulation 1998; 97: 1325-1335. |
| 10） |
ACC/AHA Task Force Report. Guidelines for Clinical Intracardiac Electrophysiological and Catheter Ablation Procedures. A report of the American College of Cardiology/American Heart Association task force on practice guidelines (Committee on Clinical Intracardiac Electrophysiologic and Catheter Ablation Procedures). Developed in collaboration with the North American Society of Pacing and Electophysiology. J Cardiovasc Electrophysiol 1995; 6: 652-679. |
| 11） |
Guidelines for Clinical Intracardiac Electrophysiological and Catheter Ablation Procedures. A report of the American College of Cardiology/American Heart Association Task Force on practice guidelines. (Committee on Clinical Intracardiac Electrophysiologic and Catheter Ablation Procedures). Developed in collaboration with the North American Society of Pacing and Electrophysiology. Circulation 1995; 92: 673-691. |
| 12） |
Gregoratos G, Abrams J, Epstein AE, Freedman RA, Hayes DL, Hlatky MA, et al: ACC/AHA/NASPE 2002 guideline update for implantation of cardiac pacemakers and antiarrhythmia devices: summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/NASPE Committee to Update the 1998 Pacemaker Guidelines). Circulation 2002; 106: 2145-2161. |
| 13） |
Meltzer S, Leiter L, Daneman D, Cerstein HC, Lau D, Ludwig S, et al: 1998 clinical practice guidelines for the management of diabetes in Canada. Canadian Diabetes Association. CMAJ 1998; 159(Suppl 8): S1-29. |
| 14） |
カテーテルアブレーション委員会：カテーテルアブレーション施行に関するガイドライン．心臓ペーシング 1990; 6: 381. |
| 15） |
Mandel WJ, Hayakawa H, Allen HN, Danzig R, Kermaier AI: Assessment of sinus node function in patients with the sick sinus syndrome. Circulation 1972; 46: 761-769. |
| 16） |
Jordan JL, Yamaguchi I, Mandel WJ: Studies on the mechanism of sinus node dysfunction in the sick sinus syndrome. Circulation 1978; 57: 217-223. |
| 17） |
Kasanuki H: Electrophysiological and clinical study of sick sinus syndrome using the overdrive suppression test. Jpn Circ J 1980; 44: 505-517. |
| 18） |
大西 哲，笠貫 宏，庄田守男，松田直樹，網代洋一，川城直美ほか：Overdrive suppression testによるSSSの分類とその意義．心電図 1996; 16: 332-339. |
| 19） |
八木 洋，鈴木秀夫，杉野敬一，渡辺高祥，高橋直之，上西 壮ほか：洞自動能，洞房伝導能に対するoverdrive suppressionの臨床的意義と自律神経系のoverdrive suppressionに及ぼす影響－洞結節電位記録法による検討－． 心電図 1996; 16: 360-368. |
| 20） |
Narula OS, Scherlag BJ, Javier RP, Hildner FJ, Samet P: Analysis of the A-V conduction defect in complete heart block utilizing His bundle electrograms. Circulation 1970; 41: 437-448. |
| 21） |
遠藤康弘，笠貫 宏，大西 哲，田中悦子，稲葉茂樹，孫崎信久ほか：ヒス束内ブロックの臨床電気生理学的検討およびその長期予後．呼と循 1986; 34: 43-49. |
| 22） |
中里祐二，中田八洲郎：高度および完全房室ブロックにおける臨床電気生理学的検討．心臓ペーシング 1987; 3: 355-363. |
| 23） |
Sra JS, Jazayeri MR, Avitall B, Dhala A, Deshpande S, Blanck Z, et al: Comparison of cardiac pacing with drug therapy in the treatment of neurocardiogenic（vasovagal） syncope with bradycardia or asystole. N Engl J Med 1993; 328: 1085-1090. |
| 24） |
諏訪二郎：洞機能不全症候群における生理的ペーシングの有用性および心房粗細動発生機序に関する検討．東女医大誌 1987; 57: 1545-1556. |
| 25） |
Scheinman MM, Peters RW, Modin G, Brennan M, Mies C, O'Young J: Prognostic value of infranodal conduction time in patients with chronic bundle branch block. Circulation 1977; 56: 240-244. |
| 26） |
Englund A, Bergfeldt L, Rosenqvist M: Pharmacological stress testing of the His-Purkinje system in patients with bifascicular block. Pacing Clin Electrophysiol 1998; 21: 1979-1987. |
| 27） |
Scheinman MM, Weiss AN, Shafton E, Benowits N, Rowland M: Electrophysiologic effects of procaine amide in patients with intraventricular conduction delay. Circulation 1974; 49: 522-529. |
| 28） |
Fananapazir L, Epstein ND, Curiel RV, Panza JA, Tripodi D, McAreavey D: Long-term results of dual-chamber (DDD) pacing in obstructive hypertrophic cardiomyopathy. Evidence for progressive symptomatic and hemodynamic improvement and reduction of left ventricular hypertrophy. Circulation 1994; 90: 2731-2742. |
| 29） |
Auricchio A, Stellbrink C, Block M, Sack S, Vogt J, Bakker P, et al: Effect of pacing chamber and atrioventricular delay on acute systolic function of paced patients with congestive heart failure. The Pacing Therapies for Congestive Heart Failure Study Group. The Guidant Congestive Heart Failure Research Group. Circulation 1999; 99: 2993-3001. |
| 30） |
早川弘一，加藤貢雄：臨床心臓電気生理学的検査．早川弘一，比江嶋一昌編集，臨床心臓電気生理学，南江堂，1988; p45-62. |
| 31） |
Hirao K, Otomo K, Wang X, Beckman KJ, McClelland JH, Widman L, et al: Para-Hisian pacing. A new method for differentiating retrograde conduction over an accessory AV pathway from conduction over the AV node. Circulation 1996; 94: 1027-1035. |
| 32） |
Takahashi A, Iesaka Y, Igawa M, Tokunaga T, Amemiya H, Fujiwara H, et al: Atrioventricular nodal physiology after slow pathway ablation. Pacing Clin Electrophysiol 1994; 17: 2137-2142. |
| 33） |
Nogami A, Suguta M, Tomita T, Naito S, Taniguchi K, Aonuma K, et al: Novel form of atrial tachycardia originating at the atrioventricular annulus. Pacing Clin Electrophysiol 1998; 21: 2691-2694. |
| 34） |
Kasanuki H, Ohnishi S, Tanaka E, Hirosawa K: Idiopathic sustained ventricular tachycardia responsive to verapamil: clinical electrocardiographic and electrophysiologic considerations. Jpn Circ J 1986; 50: 109-118. |
| 35） |
大西 哲，笠貫 宏，庄田守男，細田瑳一：心室頻拍における緩徐伝導．杉本恒明編集，不整脈学，1992; p311-320. |
| 36） |
Chinushi M: Long-term results of radiofrequency catheter ablation in non-ischemic sustained ventricular tachycardia with underlying heart disease. Nonuniform arrhythmogenic substrate and mode of ablation. Jpn Heart J 1996; 37: 183-194. |
| 37） |
Suyama K, Kurita T, Shimizu W, Matsuo K, Taguchi A, Aihara N, et al: Radiofrequency catheter ablation of concealed atrioventricular accessory pathways using a "simultaneous pacing method". Pacing Clin Electrophysiol 1998; 21: 1693-1699. |
| 38） |
Satoh M, Aizawa Y, Funazaki T, Niwano S, Ebe K, Miyajima S, et al: Electrophysiologic evaluation of asymptomatic patients with the Wolff-Parkinson-Whitte pattern. Pacing Clin Electrophysiol 1989; 12: 413-420. |
| 39） |
Kasanuki H, Ohnishi S, Hirosawa K: Availability of electrophysiological approach to the selection and assessment of antiarrhythmic drugs for recurrent ventricular tachycardia. Jpn Circ J 1983; 47: 105-123. |
| 40） |
Kasanuki H, Onishi S, Hirosawa K: The Usefulness of electrophysiological-pharmacologic studies in the long-term therapy of paroxysmal tachycardias. Jpn Circ J 1985; 49: 351-361. |
| 41） |
Ebe K, Aizawa Y, Shibata A: Clinical characteristics and EPS-guided therapy in 142 cases of sustained ventricular tachycardia. Jpn Heart J 1996; 37: 73-84. |
| 42） |
Niwano S, Furushima H, Taneda K, Abe A, Ohira K, Aizawa Y: The usefulness of Holter monitoring in selecting pharmacologic therapy for patients with sustained monomorphic ventricular tachycardia: studies in patients in whom no effective pharmacologic therapy could be determined by electrophysiologic study. Jpn Circ J 1998; 62: 347-352. |
| 43） |
Kasanuki H, Ohnishi S, Nirei T, Shoda M, Hosoda S: Evaluation of proarrhythmic effect of antiarrhythmic drugs on ventricular tachycardia associated with congestive heart failure. Jpn Circ J 1992; 56: 69-76. |
| 44） |
Chinushi M, Aizawa Y, Miyajima S, Funazaki T, Tamura M, Shibata A: Proarrhythmic effects of antiarrhythmic drugs assessed by electrophysiologic study in recurrent sustained ventricular tachycardia. Jpn Circ J 1991; 55: 133-141. |
| 45） |
Mason JW: A comparison of seven antiarrhythmic drugs in patients with ventricular tachyarrhythmias. Electrophysiologic Study versus Electrocardiographic Monitoring Investigators. N Engl J Med 1993; 329: 452-458. |
| 46） |
Niwano S, Yamaura M, Yoshizawa N, Moriguchi M, Kitano Y, Aizawa Y, et al: Electrophysiologic parameters to predict clinical recurrence of ventricular tachycardia in patients under electrophysiologic study-guided effective pharmacological therapy. Jpn Circ J 1999; 63: 674-680. |
| 47） |
土屋素子，笠貫 宏 |
| 48） |
A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias. The Antiarrhythmics versus Implantable Defibrillators (AVID) Investigators. N Engl J Med 1997; 337: 1576-1583. |
| 49） |
Iesaka Y, Nogami A, Aonuma K, Nitta J, Chun YH, Fujiwara H，et al: Prognostic significance of sustained monomorphic ventricular tachycardia induced by programmed ventricular stimulation using up to triple extrastimuli in survivors of acute myocardial infarction. Am J Cardiol 1990; 65: 1057-1063. |
| 50） |
Miyajima S, Aizawa Y, Suzuki K, Satoh M, Niwano S, Ebe K, et al: Sustained ventricular tachycardia responsive to verapamil in patients with hypertrophic cardiomyopathy. Clinical and electrophysiological assessment of drug efficacy. Jpn Heart J 1989; 30: 241-249. |
| 51） |
Iesaka Y, Hiroe M, Aonuma K, Nitta J, Nogami A, Tokunaga T, et al: Usefulness of electrophysiologic study and endomyocardial biopsy in differentiating arrhythmogenic right ventricular dysplasia from idiopathic right ventricular tachycardia. Heart Vessels Suppl 1990; 5: 65-69. |
| 52） |
Takahashi M, Kimura M, Kobayashi I, Aizawa Y, Shibata A: Clinical value of electrophysiologic study in patients with nonsustained ventricular tachycardia. Jpn Heart J 1994; 35: 141-151. |
| 53） |
Shimizu W, Ohe T, Kurita T, Takaki H, Aihara N, Kamakura S, et al: Early afterdepolarizations induced by isoproterenol in patients with congenital long QT syndrome. Circulation 1991; 84: 1915-1923. |
| 54） |
Washizuka T, Aizawa Y, Chinushi M, Niwano S: QT prolongation induced by intracoronary acetylcholine in congenital long QT syndrome. Heart Vessels Suppl 1995; 9: 224-226. |
| 55） |
Ohe T, Kurita T, Aihara N, Kamakura S, Matsuhisa M, Shimomura K: Electrocardiographic and electrophysiologic studies in patients with torsades de pointe--role of monophasic action potentials. Jpn Circ J 1990; 54: 1323-1330. |
| 56） |
戸兵雄子，中沢 潔，小沢 敦，田中 修，綿貫麻里子，高木明彦ほか：右脚ブロックパターンとST上昇型心電図の疫学．心電図 1995; 15: 223-226. |
| 57） |
Fujimori K, Hen Y, Hirata N, Yonemura F, Fujii S, Tanizaki K, et al: Incidence of asymptomatic Burugada syndrome among middle to High-aged subjects: An exhaustive investigation of local residents in Miyagi Prefecture. Jpn Circ J 2001; 65(Suppl 1): 504(abstract). |
| 58） |
Atarashi H, Ogawa S, Harumi K, Hayakawa H, Sugimoto T, Okada R: Characteristics of patients with right bundle branch block and ST-segment elevation in right precordial leads. Idiopathic Ventricular Fibrillation Investigators. Am J Cardiol 1996; 78: 581-583. |
| 59） |
Aizawa Y, Naitoh N, Washizuka T, Takahashi K, Uchiyama H, Shiba M, et al: Electrophysiological findings in idiopathic recurrent ventricular fibrillation: special reference to mode of induction, drug testing, and long-term outcomes. Pacing Clin Electrophysiol 1996; 19: 929-939. |
| 60） |
Ozawa Y, Yakubo S, Tanigawa N, Nagasawa M, Kojima R, Jinno K, et al: The clinical evaluation of the late potentials in patients with ventricular arrhythmias. Jpn Circ J 1987; 51: 230-241. |
| 61） |
南家俊彦，村山正博：心室遅延電位による拡張型心筋症の突然死予知・心筋梗塞との比較．聖マリアンナ医大誌 1994; 22: 893-897. |
| 62） |
早川弘一，田中茂夫，笠貫 宏，加藤貴雄，小林義典，八島正明：心臓ペースメーカー植込みに関するガイドライン（1995年）．心臓ペーシング 1995; 11: 6-10. |
| 63） |
戸叶隆司，中田八洲郎，安田正之，松本佳久，大野安彦，久岡英彦ほか：His-Purkinje系におけるWenckebach型房室ブロックの臨床電気生理学的検討．心電図 1996; 16: 1-14. |
| 64） |
Sumiyoshi M, Nakata Y, Yasuda M, Tokano Y, Ohno Y, Ogura S, et al: Changes of conductivity in patients with secondor third-degree atrioventricular block after pacemaker implantation. Jpn Circ J 1995; 59: 284-291. |
| 65） |
Nakazato Y, Nakata Y, Takano T, Yasuda M, Ohno Y, Hisaoka T, et al: Intra-His bundle block corresponds with interruption of the branching portion of the His bundle. Pacing Clin Electrophysiol 1994; 17: 1124-1133. |
| 66） |
住吉正孝：ヒス束内ブロックの臨床的・電気生理学的，および病理組織学的検討．順天堂医 1988; 34: 344-456. |
| 67） |
戸叶隆司，中田八洲郎，安田正之，大野安彦，松本佳久，久岡英彦ほか：一過性房室ブロック例におけるIa群抗不整脈薬静注による房室ブロック誘発に関する検討．心臓 1997; 29: 193-204. |
| 68） |
中田八洲郎：徐脈性不整脈における臨床電気生理学的検討．心電図 1982; 2（別冊: 第1回合同学術集会抄録集）: 111-115. |
| 69） |
Glikson M, Dearani JA, Hyberger LK, Schaff HV, Hammill SC, Hayes DL: Indications, effectiveness, and long-term dependency in permanent pacing after cardiac surgery. Am J Cardiol 1997; 80: 1309-1313. |
| 70） |
Langberg JJ, Chin MC, Rosenqvist M, Cockrell J, Dullet N, Van Hare G, et al: Catheter ablation of the atrioventricular junction with radiofrequency energy. Circulation 1989; 80: 1527-1535. |
| 71） |
Strasberg B, Amat-Y-Leon F, Dhingra RC, Palileo E, Swiryn S, Bauernfeind R, et al: Natural history of chronic second-degree atrioventricular nodal block. Circulation 1981; 63: 1043-1049. |
| 72） |
Ector H, Rolies L, De Geest H: Dynamic electrocardiography and ventricular pauses of 3 seconds and more:etiology and therapeutic implications. Pacing Clin Electrophysiol 1983; 6: 548-551. |
| 73） |
Penton GB, Miller H, Levine S: Some clinical features of complete heart block. Circulation 1956; 13: 801-824. |
| 74） |
McAnulty JH, Rahimtoola SH, Murphy E, DeMots H, Ritzmann L, Kanarek PE, et al: Natural history of "highrisk" bundle-branch block: final report of a prospective study. N Engl J Med 1982; 307: 137-143. |
| 75） |
Scheinman MM, Peters RW, Suavé MJ, Desai J, Abbott JA, Cogan J, et al: Value of H-Q interval in patients with bundle branch block and the role of prophylactic permanent pacing. Am J Cardiol 1982; 50: 1316-1322. |
| 76） |
Dhingra RC, Wyndham C, Bauernfeind R, Swiryn S, Deedwania PC, Smith T, et al: Significance of block distal to the His bundle induced by atrial pacing in patients with chronic bifascicular block. Circulation 1979; 60: 1455-1464. |
| 77） |
Shaw DB, Holman RR, Gowers JI: Survival in sinoatrial disorder (sick-sinus syndrome). Br Med J 1980; 280: 139-141. |
| 78） |
Kay R, Estioko M, Wiener I: Primary sick sinus syndrome as an indication for chronic pacemaker therapy in young adults: incidence, clinical features, and long-term evaluation. Am Heart J 1982; 103: 338-342. |
| 79） |
Kusumoto FM, Goldschlager N: Cardiac pacing. N Engl J Med 1996; 334: 89-97. |
| 80） |
Dreifus LS, Michelson EL, Kaplinsky E: Bradyarrhythmias: clinical significance and management. J Am Coll Cardiol 1983; 1: 327-338. |
| 81） |
Rasmussen K: Chronic sinus node disease: natural course and indications for pacing. Eur Heart J 1981; 2: 455-459. |
| 82） |
Rubenstein JJ, Schulman CL, Yurchak PM, DeSanctis RW: Clinical spectrum of the sick sinus syndrome. Circulation 1972; 46: 5-13. |
| 83） |
木谷文博，深谷真彦，王 文雄，早野元信，矢野捷介，持永俊一ほか：洞不全症候群における人工ペースメーカ植込み適応基準と長期成績．心臓 1977; 9: 904-910. |
| 84） |
Fukatani M, Hashiba K: Long-term follow-up after cardiac pacing in bradyarrhythmias. Jpn Circ J 1978; 42: 257-268. |
| 85） |
Yanaga T, Otsuka K, Ichimaru Y, Hata Y, Okamoto K, Nakanishi H, et al: Usefulness of 24-hour recordings of electrocardiogram for the diagnosis and treatment of arrhythmias with special reference to the determination of indication of artificial cardiac pacing. Jpn Circ J 1981; 45: 366-375. |
| 86） |
加藤貴雄：Sick sinus syndrome: 特にoverdrive suppression testの評価ならびに自然発作と誘発発作の比較．日医大誌 1980; 47: 245-249. |
| 87） |
岡野和弘：Sick sinus症候群の不整脈発作の日内変動に関する研究．日医大誌 1983; 50: 501. |
| 88） |
笠貫 宏：徐脈頻脈症候群の臨床的特徴．平岡昌和，橋場邦武編集，洞結節，金原出版，1987; p139-156. |
| 89） |
Phibbs B, Friedman HS, Graboys TB, Lown B, Marriott HJ, Nelson WP, et al: Indications for pacing in the treatment of bradyarrhythmias. Report of an independent study group. JAMA 1984; 252: 1307-1311. |
| 90） |
Ishikawa T, Sumita S, Kimura K, Kikuchi M, Kosuge M, Endo T, et al: Sinus node recovery time assessment by the overdrive suppression test employing an intravenous injection of disopyramide phosphate. Europace 2000; 2: 54-59. |
| 91） |
松浦雄一郎，田村陸奥夫，山科秀機，肥後正徳，山田和明，向井正祁ほか：心房細動下徐脈例に対するpace-maker植え込みによる治験例の検討．日臨 1980; 38: 2008-2012. |
| 92） |
Pitcher D, Papouchado M, James MA, Rees JR: Twenty four hour ambulatory electrocardiography in patients with chronic atrial fibrillation．Br Med J (Clin Res Ed) 1986; 292: 594. |
| 93） |
Pollak A, Falk RH: Pacemaker therapy in patients with atrial fibrillation. Am Heart J 1993; 125: 824-830. |
| 94） |
Peretz DI, Gerein AN, Miyagishima RT: Permanent demand pacing for hypersensitive carotid sinus syndrome. Can Med Assoc J 1973; 108: 1131-1134. |
| 95） |
Kenny RA, Ingram A, Bayliss J, Sutton R: Head-up tilt: a useful test for investigating unexplained syncope. Lancet 1986; 1: 1352-1355. |
| 96） |
Fitzpatrick A, Sutton R: Tilting towards a diagnosis in recurrent unexplained syncope. Lancet 1989; 1: 658-660. |
| 97） |
池野文昭，鈴木康正：血管迷走神経性失神の3例－その特徴とペースメーカー治療の適応について－．心臓ペーシング 1989; 5: 68-77. |
| 98） |
Brignole M, Menozzi C, Gianfranchi L, Oddone D, Lolli G, Bertulla A: Neurally mediated syncope detected by carotid sinus massage and head-up tilt test in sick sinus syndrome. Am J Cardiol 1991; 68: 1032-1036. |
| 99） |
Sutton R, Petersen M, Brignole M, Raviele A, Menozzi C, Giani P: Proposed classification for tilt-induced vasovagal syncope. Eur J Cardiac Pacing Electrophysiol 1992; 2: 180-183. |
| 100） |
別役徹生，熊本秀樹，横武尚司，野村徳之，吉田 泉，桜井正之ほか：静脈穿刺で発現した血管迷走神経反射性失神の1例．呼と循 1992; 40: 831-833. |
| 101） |
Petersen ME, Chamberlain-Webber R, Fitzpatrick AP, Ingram A, Williams T, Sutton R: Permanent pacing for cardioinhibitory malignant vasovagal syndrome. Br Heart J 1994; 71: 274-281. |
| 102） |
Nishizaki M, Arita M, Sakurada H, Ohta T, Yamawake N, Numano F, et al: Long-term follow-up of the reproducibility of carotid sinus hypersensitivity in patients with carotid sinus syndrome. Jpn Circ J 1995; 59: 33-39. |
| 103） |
菊嶋修示，小林洋一，向井英之，馬場隆男，蔵野康造，丹野 郁ほか：失神発作に対するhead-up tilt testの有用性：ペースメーカー植込み後も失神，眩暈を繰り返した症例の検討．心臓ペーシング 1995; 11: 421-427. |
| 104） |
Benditt DG, Ferguson DW, Grubb BP, Kapoor WN, Kugler J, Lerman BB, et al: Tilt table testing for assessing syncope. American College of Cardiology. J Am Coll Cardiol 1996; 28: 263-275. |
| 105） |
Grubb BP, Gerard G, Roush K, Temesy-Armos P, Elliott L, Hahn H, et al: Differentiation of convulsive syncope and epilepsy with head-up tilt testing. Ann Intern Med 1991; 115: 871-876. |
| 106） |
Sumiyoshi M, Nakata Y, Mineda Y: Paroxysmal atrioventricular block induced during head-up tilt testing in an apparently healthy man. J Cardiovasc Electrophysiol 1997; 8: 561-564. |
| 107） |
Connolly SJ, Sheldon R, Roberts RS, Gent M: The North American Vasovagal Pacemaker Study (VPS). A randomized trial of permanent cardiac pacing for the prevention of vasovagal syncope. J Am Coll Cardiol 1999; 33: 16-20. |
| 108） |
山分規義，西崎光弘，足利貴志，有田匡孝，桜田春水，沼野藤夫ほか：頚動脈洞症候群に対するrate-drop response作動ペースメーカーの検討．不整脈 2000; 16: 29-35. |
| 109） |
Ammirati F, Colivicchi F, Santini M, Syncope Diagnosis and Treatment Study Investigators: Permanent cardiac pacing versus medical treatment for the prevention of recurrent vasovagal syncope: a multicenter, randomised, controlled trial. Circulation 2001; 104: 52-57. |
| 110） |
Gilgenkrantz JM, Cherrier F, Petitier H, Dodinot B, Houplon M, Legoux J: [Obstructive cardiomyopathy of the left ventricle with complete auriculo-ventriculrar block. Therapeutic considerations]. Arch Mal Coeur Vaiss 1968; 61:439-453. Article in French |
| 111） |
Hassenstein P, Storch HH, Schmitz W: [Results of electrical pacing in patients with hypertrophic obstruction cardiomyopathy (author's transl)]. Thoraxchir Vask Chir 1975; 23: 496-498. Article in German |
| 112） |
Duport G, Valeix B, Lefevre J, Nebunu JC, Bouteau JM, Garcia-Duport M, et al: [Importance of permanent right ventricular stimulation in obstructive cardiomyopathy]. Nouv Presse Med 1978; 7: 2868-2869. Article in French |
| 113） |
McDonald K, McWilliams E, O'Keeffe B, Maurer B: Functional assessment of patients treated with permanent dual chamber pacing as a primary tretment for hypertrophic cardiomyopathy. Eur Heart J 1988; 9: 893-898． |
| 114） |
Jeanrenaud X, Goy JJ, Kappenberger L: Effects of dual-chamber pacing in hypertrophic obstructive cardiomyopathy. Lancet 1992; 339: 1318-1323. |
| 115） |
Fananapazir L, Epstein ND, Curiel RV, Panza JA, Tripodi D, McAreavey D: Long-term results of dual-chamber (DDD) pacing in obstructive hypertrophic cardiomyopathy. Evidence for progressive symptomatic and hemodynamic improvement and reduction of left ventricular hypertrophy. Circulation 1994; 90: 2731-2742． |
| 116） |
Maron BJ, Nishimura RA, McKenna WJ, Rakowski H, Josephson ME, Kieval RS: Assessment of permanent dual-chamber pacing as a treatment for drug-refractory symptomatic patients with obstructive hypertrophic cardiomyopathy. A randomized, double-blind, crossover study (M-PATHY). Circulation 1999; 99: 2927-2933. |
| 117） |
Kappenberger LJ, Linde C, Jeanrenaud X, Daubert C, McKenna W, Meisel E, et al: Clinical progress after randomized on/off pacemaker treatment for hypertrophic obstructive cardiomyopathy. Pacing in Cardiomyopathy (PIC) Study Group. Europace 1999; 1: 77-84. |
| 118） |
Sakai Y, Kawakami Y, Hirota Y, Ito T, Shimada S, Tokaji Y, et al: Dual-chamber pacing in hypertrophic obstructive cardiomyopathy: a comparison of acute and chronic effects. Jpn Circ J 1999; 63: 971-975. |
| 119） |
Meisel E, Rauwolf T, Burghardt M, Kappenberger L: [Pacemaker therapy of hypertrophic obstructive cardiomyopathy. PIC (Pacing in Cardiomyopathy) Study Group]. Herz 2000; 25: 461-466. Article in German |
| 120） |
Ommen SR, Nishimura RA, Squires RW, Schaff HV, Danielson GK, Tajik AJ: Comparison of dual-chamber pacing versus septal myectomy for the treatment of patients with hypertrophic obstructive cardiomyopathy: a comparison of objective hemodynamic and exercise end points. J Am Coll Cardiol 1999: 34: 191-196. |
| 121） |
古賀義則，鄭 忠和，濱田希臣，川副浩平，松本万夫，高山守正：閉塞性肥大型心筋症の治療．循環器医 2000; 8: 249-266. |
| 122） |
Michaëlsson M, Jonzon A, Riesenfeld T: Isolated congenital complete atrioventricular block in adult life. A prospective study. Circulation 1995; 92: 442-449. |
| 123） |
Pinsky WW, Gillette PC, Garson A, McNamara DG: Diagnosis, management, and long-term results of patients with congenital complete atrioventricular block. Pediatrics 1982; 69: 728-733. |
| 124） |
Sholler GF, Walsh EP: Congenital complete heart block in patients without anatomic cardiac defects. Am Heart J 1989; 118: 1193-1198. |
| 125） |
Dewey RC, Capeless MA, Levy AM: Use of ambulatory electrocardiographic monitoring to identify high-risk patients with congenital complete heart block. N Engl J Med 1987; 316: 835-839. |
| 126） |
Lillehei CW, Sellers RD, Bonnabeau RC, Eliot RS: Chronic postsurgical complete heart block. With particular reference to prognosis, management, and a new p-wave pacemaker. J Thorac Cardiovasc Surg 1963; 46: 436-456. |
| 127） |
Krongrad E: Prognosis for patients with congenital heart disease and postoperative intraventricular conduction defects. Circulation 1978; 57: 867-870. |
| 128） |
Gelatt M, Hamilton RM, McCrindle BW, Connelly M, Dabis A, Harris L, et al: Arrhythmia and mortality after the Mustard procedure: a 30-year single-center experience, J Am Coll Cardiol 1997; 29: 194-201. |
| 129） |
福本仁志，西本 孝，大関道麿，佐々木進次郎，武内淳郎，長岡 透：小児におけるペースメーカー植え込み方法の検討．臨胸外 1986; 6: 64-67. |
| 130） |
木曽一誠，廣谷 隆，前原正明，四津良平，梅津泰洋，石倉義成：小児のペースメーカー植え込み術の検討－胸腔内植込み術の評価－．胸部外科 1990; 43: 280-282. |
| 131） |
水野朝敏，中村 譲，高安英樹，斉藤寛史，森 彪：小児のペースメーカー治療．埼玉医会誌 1991; 26: 307-311. |
| 132） |
水野朝敏，益子健男，斎藤文美恵，斉藤寛史，中村 譲，黒澤博身：小児ペースメーカー治療の問題点．人工臓器 1993; 22: 868-871. |
| 133） |
小田勝志，安藤史隆，岡本文雄，山中一朗，大谷成裕，松野修一ほか：小児期ペースメーカー植え込み症例の臨床的検討－腋窩皮下植え込み法の有用性－．胸部外科 1993; 46: 911-917. |
| 134） |
熊手宗隆，福永周司，青柳成明，小須賀健一，大石喜六，橋野かの子ほか：31例の小児，乳幼児に対して行ったペースメーカー植込み術の検討．心臓ペーシング 1996; 12: 350-354. |
| 135） |
寺田正次，高梨吉則，今井康晴：小児期心臓血管外科における人工弁，ペースメーカー，人工血管の現状．小児外科 1998; 30: 128-132. |
| 136） |
尾崎喜就，山口眞弘，大橋秀隆，今井雅尚，大嶋義博，熊本隆之ほか：小児のDDDペースメーカー植え込み症例の検討－左前側方開胸のアプローチによる心外膜電極装着．日胸外会誌 1997; 45: 1601-1605. |
| 137） |
Gallagher JJ, Svenson RH, Kasell JH, German LD, Bardy GH, Broughton A, et al: Catheter technique for closed-chest ablation of the atrioventricular conduction system. N Engl J Med 1982; 306: 194-200. |
| 138） |
Huang SK, Bharati S, Graham AR, Lev M, Marcus FI, Odell RC: Closed chest catheter desiccation of the atrioventricular junction using radiofrequency energy--a new method of catheter ablation. J Am Coll Cardiol 1987; 9: 349-358. |
| 139） |
Langberg JJ, Chin M, Schamp DJ, Lee MA, Goldberger J, Pederson DN, et al: Ablation of the atrioventricular junction with radiofrequency energy using a new electrode catheter. Am J Cardiol 1991; 67: 142-147. |
| 140） |
笠貫 宏，杉本恒明，比江嶋一昌，相澤義房，大江 透，鎌倉史郎ほか：1994年以降のカテーテル・アブレーションの症例調査に関する報告．不整脈 1999; 15: 353-358. |
| 141） |
Calkins H, Sousa J, el-Atassi R, Rosenheck S, de Buitleir M, Kou WH, et al: Diagnosis and cure of the Wolff-Parkinson-White syndrome or paroxysmal supraventricular tachycardias during a single electrophysiologic test. N Engl J Med 1991; 324: 1612-1618. |
| 142） |
Jackman WM, Wang XZ, Friday KJ, Roman CA, Moulton KP, Beckman KJ, et al: Catheter ablation of accessory atrioventricular pathways (Wolff-Parkinson-White syndrome) by radiofrequency current. N Engl J Med 1991; 324: 1605-1611. |
| 143） |
Kuck KH, Schlüter M, Geiger M, Siebels J, Duckeck W: Radiofrequency current catheter ablation of accessory atrioventricular pathways. Lancet 1991; 337: 1557-1561. |
| 144） |
Calkins H, Langberg J, Sousa J, el-Atassi R, Leon A, Kou W, et al: Radiofrequency catheter ablation of accessory atrioventricular connections in 250 patients. Abbreviated therapeutic approach to Wolff-Parkinson-White syndrome. Circulation 1992; 85: 1337-1346. |
| 145） |
Hindricks G: The Multicentre European Radiofrequency Survey (MERFS): complications of radiofrequency catheter ablation of arrhythmias. The Multicentre European Radiofrequency Survey (MERFS) investigators of the Working Group on Arrhythmias of the European Society of Cardiology. Eur Heart J 1993; 14: 1644-1653. |
| 146） |
Lesh MD, Van Hare GF, Scheinman MM, Ports TA, Epstein LA: Comparison of the retrograde and transseptal methods for ablation of left free wall accessory pathways. J Am Coll Cardiol 1993; 22: 542-549. |
| 147） |
Scheinman MM: NASPE Survey on Catheter Ablation. Pacing Clin Electrophysio 1995; 18: 1474-1478. |
| 148） |
Calkins H, Yong P, Miller JM, Olshansky B, Carlson M, Saul JP, et al: Catheter ablation of accessory pathways, atrioventricular nodal reentrant tachycardia, and the atrioventricular junction: final results of a prospective, multicenter clinical trial. The Atakr Multicenter Investigators Group. Circulation 1999; 99: 262-270. |
| 149） |
Scheinman MM, Huang S: The 1998 NASPE prospective catheter ablation registry. Pacing Clin Electrophysiol 2000; 23: 1020-1028. |
| 150） |
Antz M, Weiss C, Volkmer M, Hebe J, Ernst S, Ouyang F, et al: Risk of sudden death after successful accessory atrioventricular pathway ablation in resuscitated patients with Wolff-Parkinson-White syndrome. J Cardiovasc Electrophysiol 2002; 13: 231-236. |
| 151） |
Akhtar M, Jazayeri MR, Sra J, Blanck Z, Deshpande S, Dhala A: Atrioventricular nodal reentry. Clinical, electrophysiological, and therapeutic considerations. Circulation 1993; 88: 282-295. |
| 152） |
Bogun F, Knight B, Weiss R, Bahu M, Goyal R, Harvey M, et al: Slow pathway ablation in patients with documented but noninducible paroxysmal supraventricular tachycardia. J Am Coll Cardiol 1996; 28: 1000-1004. |
| 153） |
Rostock T, Risius T, Ventura R, Klemm HU, Weiss C, Keitel A, et al: Efficacy and safety of radiofrequency catheter ablation of atrioventricular nodal reentrant tachycardia in the elderly. J Cardiovasc Electrophysiol 2005; 16: 608-610. |
| 154） |
梅村 純，笠貫 宏，大西 哲，庄田守男，細田瑳一：WPW症候群に対する高周波カテーテル・アブレーション．心臓ペーシング 1996; 12: 498-505. |
| 155） |
池口 滋，綿貫正人，竹岡 玲，奥田和美，石川 昇，橋本哲男ほか：WPW症候群に対する高周波カテーテル・アブレーション．－複数副伝導路症例に関する検討－．心電図 1998; 18 :413-423. |
| 156） |
加藤 勲，岩 亨，太田隆之，鈴木靖司，米津益人，福田祥子ほか：WPW症候群患者におけるカテーテル・アブレーション－副伝導路の伝導再開により上室性頻拍症が再発した症例の検討－．不整脈 2004; 20: 571-578. |
| 157） |
Iesaka Y, Takahashi A, Goya M, Yamane T, Kojima S, Fujiwara H, et al: Selective radiofrequency catheter ablation of the slow pathway for common and uncommon atrioventricular nodal reentrant tachycardia. Jpn Heart J 1996; 37: 759-770. |
| 158） |
AFFIRM |
| 159） |
Stabile G, Bertaglia E, Senatore G, de Simone A, Zerbo F, Carreras G, et al: Feasibility of pulmonary vein ostia radiofrequency ablation in patients with atrial fibrillation: a multicenter study (CACAF pilot study). Pacing Clin Electrophysiol 2003; 26: 284-287. |
| 160） |
Wazni OM, Marrouche NF, Martin DO, Verma A, Bhargava M, Saliba W, et al: Radiofrequency ablation vs antiarrhythmic drugs as first-line treatment of symptomatic atrial fibrillation: a randomized trial. JAMA 2005; 293: 2634-2640. |
| 161） |
Oral H, Pappone C, Chugh A, Good E, Bogun F, Pelosi F, et al: Circumferential pulmonary-vein ablation for chronic atrial fibrillation. N Engl J Med 2006; 354: 934-941. |
| 162） |
Haïssaguerre M, Shah DC, Jaïs P, Hocini M, Yamane T, Deisenhofer I, et al: Electrophysiological breakthroughs from the left atrium to the pulmonary veins. Circulation 2000; 102: 2463-2465. |
| 163） |
Pappone C, Rosanio S, Oreto G, Tocchi M, Gugliotta F, Vicedomini G, et al: Circumferential radiofrequency ablation of pulmonary vein ostia: A new anatomic approach for curing atrial fibrillation. Circulation 2000; 102: 2619-2628. |
| 164） |
Cappato R, Calkins H, Chen SA, Davies W, Iesaka Y, Kalman J, et al: Worldwide survey on the methods, efficacy, and safety of catheter ablation for human atrial fibrillation. Circulation 2005; 111: 1100-1105. |
| 165） |
Pappone C, Oral H, Santinelli V, Vicedomini G, Lang CC, Manguso F, et al: Atrio-esophageal fistula as a complication of percutaneous transcatheter ablation of atrial fibrillation. Circulation 2004; 109: 2724-2726. |
| 166） |
Hsu LF, Jaïs P, Sanders P, Garrigue S, Hocini M, Sacher F, et al: Catheter ablation for atrial fibrillation in congestive heart failure. N Engl J Med 2004; 351: 2373-2383. |
| 167） |
Nademanee K, McKenzie J, Kosar E, Schwab M, Sunsaneewitayakul B, Vasavakul T, et al: A new approach for catheter ablation of atrial fibrillation: mapping of the eletrophysiologic substrate. J Am Coll Cardiol 2004; 43: 2044-2053. |
| 168） |
Williamson BD, Man KC, Daoud E, Niebauer M, Strickberger SA, Morady F: Radiofrequency catheter modification of atrioventricular conduction to control the ventricular rate during
atrial fibrillation. N Engl J Med 1994; 331: 910-917. |
| 169） |
Feld GK, Fleck RP, Chen PS, Boyce K, Bahnson TD, Stein JB, et al: Radiofrequency catheter ablation for the treatment of human type 1 atrial flutter. Identification of a critical zone in the reentrant circuit by endocardial mapping techniques. Circulation 1992; 86: 1233-1240. |
| 170） |
Lee SH, Tai CT, Yu WC, Chen YJ, Hsieh MH, Tsai CF, et al: Effects of radiofrequency catheter ablation on quality of life in patients with atrial flutter. Am J Cardiol 1999; 84: 278-283. |
| 171） |
Cheng J, Cabeen WR, Scheinman MM: Right atrial flutter due to lower loop reentry: mechanism and anatomic substrates. Circulation 1999; 99: 1700-1705. |
| 172） |
Triedman JK, Alexander ME, Berul CI, Bevilacqua LM, Walsh EP : Electroanatomic mapping of entrained and exit zones in patients with repaired congenital heart disease and intra-atrial reentrant tachycardia. Circulation 2001; 103: 2060-2065. |
| 173） |
Goya M, Iesaka Y, Takahashi A, Mitsuhashi T, Yamane T, Soejima Y, et al: Radiofrequency catheter ablation for sinoatrial node reentrant tachycardia: electrophysiologic features of ablation sites. Jpn Circ J 1999; 63: 177-183. |
| 174） |
Iesaka Y, Takahashi A, Goya M, Soejima Y, Okamoto Y, Fujiwara H, et al: Adenosine-sensitive atrial reentrant tachycardia originating from the atrioventricular nodal transitional area. J Cardiovasc Electrophysiol 1997; 8: 854-864. |
| 175） |
Chen SA, Tai CT, Chiang CE, Ding YA, Chang MS: Focal atrial tachycardia: reanalysis of the clinical and electrophysiologic characteristics and prediction of successful radiofrequency ablation. J Cardiovasc Electrophysiol 1998; 9: 355-365. |
| 176） |
Chen SA, Chiang CE, Yang CJ, Cheng CC, Wu TJ, Wang SP, et al: Sustained atrial tachycardia in adult patients. Electrophysiological characteristics, pharmacological response, possible mechanisms, and effects of radiofrequency ablation. Circulation 1994; 90: 1262-1278. |
| 177） |
Man KC, Knight B, Tse HF, Pelosi F, Michaud GF, Flemming M, et al: Radiofrequency catheter ablation of inappropriate sinus tachycardia guided by activation mapping. J Am Coll Cardiol 2000; 35: 451-457. |
| 178） |
Callans DJ, Ren JF, Schwartzman D, Gottlieb CD, Chaudhry FA, Marchlinski FE: Narrowing of the superior vena cava-right atrium junction during radiofrequency catheter ablation for inappropriate sinus tachycardia: analysis with intracardiac echocardiography. J Am Coll Cardiol 1999; 33: 1667-1670. |
| 179） |
Okishige K, Goseki Y, Itoh A, Tsuboi N, Sasano T, Azegami K, et al: New electrophysiologic features and catheter ablation of atrioventricular and atriofascicular accessory pathways: evidence of decremental conduction and the anatomic structure of the Mahaim pathway. J Cardiovasc Electrophysiol 1998; 9: 22-33. |
| 180） |
Kusumoto FM, Lesh MD: Radiofrequency catheter ablation of an atriofascicular connection guided by direct recording of a Mahaim potential. Am Heart J 1995; 129: 614-616. |
| 181） |
McClelland JH, Wang X, Beckman KJ, Hazlitt HA, Prior MI, Nakagawa H, et al: Radiofrequency catheter ablation of right atriofascicular (Mahaim) accessory pathways guided by accessory pathway activation potentials. Circulation 1994; 89: 2655-2666. |
| 182） |
Haïssaguerre M, Shah DC, Jaïs P, Shoda M, Kautzner J, Arentz T, et al: Role of Purkinje conducting system in triggering of idiopathic ventricular fibrillation. Lancet 2002; 359: 677-678. |
| 183） |
Haïssaguerre M, Shoda M, Jaïs P, Nogami A, Shah DC, Kautzner J, et al: Mapping and ablation of idiopathic ventricular fibrillation. Circulation 2002; 106: 962-967. |
| 184） |
Nagasawa H, Fujiki A, Usui M, Mizumaki K, Hayashi H, Inoue H: Successful radiofrequency catheter ablation of incessant ventricular tachycardia with a delta wave-like beginning of the QRS complex. Jpn Heart J 1999; 40: 671-675. |
| 185） |
Shimoike E, Ueda N, Maruyama T, Kaji Y: Radiofrequency catheter ablation of upper septal idiopathic left ventricular tachycardia exhibiting left bundle branch block morphology. J Cardiovasc Electrophysiol 2000; 11: 203-207. |
| 186） |
Nogami A, Naito S, Tada H, Oshima S, Taniguchi K, Aonuma K, et al: Verapamil-sensitive left anterior fascicular ventricular tachycardia: results of radiofrequency ablation in six patients. J Cardiovasc Electrophysiol 1998; 9: 1269-1278. |
| 187） |
Tada H, Nogami A, Naito S, Tomita T, Oshima S, Taniguchi K, et al: Retrograde Purkinje potential activation during sinus rhythm following catheter ablation of idiopathic left ventricular tachycardia. J Cardiovasc Electrophysiol 1998; 9: 1218-1224. |
| 188） |
Kamakura S, Shimizu W, Matsuo K, Taguchi A, Suyama K, Kurita T, et al: Localization of optimal ablation site of idiopathic ventricular tachycardia from right and left ventricular outflow tract by body surface ECG. Circulation 1998; 98: 1525-1533. |
| 189） |
Chinushi M, Aizawa Y, Ohhira K, Fujita S, Shiba M, Niwano S, et al: Repetitive ventricular responses induced by radiofrequency ablation for idiopathic ventricular tachycardia originating from the outflow tract of the right ventricle. Pacing Clin Electrophysiol 1998; 21: 669-678. |
| 190） |
Washizuka T, Aizawa Y, Chinushi M, Naitoh N, Miyajima T, Kusano Y, et al: Alternation of QRS morphology and effect of radiofrequency ablation in idiopathic ventricular tachycardia. Pacing Clin Electrophysiol 1995; 18: 18-27. |
| 191） |
Nakagawa H, Beckman KJ, McClelland JH, Wang X, Arruda M, Santoro I, et al: Radiofrequency catheter ablation of idiopathic left ventricular tachycardia guided by a Purkinje potential. Circulation 1993; 88: 2607-2617. |
| 192） |
Kusano KF, Emori T, Morita H, Ohe T: Ablation of ventricular tachycardia by isolating the critical site in a patient with arrhythmogenic right ventricular cardiomyopathy. J Cardiovasc Electrophysiol 2000; 11: 102-105. |
| 193） |
Harada T, Aonuma K, Yamauchi Y, Igawa M, Hachiya H, Oh JC, et al: Catheter ablation of ventricular tachycardia in patients with right ventricular dysplasia: Identification of target sites by entrainment mapping techniques. Pacing Clin Electrophysiol 1998; 21: 2547-2550. |
| 194） |
Yamauchi Y, Nogami A, Naito S, Tsuchio Y, Aonuma K, Iesaka Y, et al: Catheter ablation for ventricular tachycardia from a diverticulum at the right ventricular outflow tract. Pacing Clin Electrophysiol 1998; 21: 1835-1836. |
| 195） |
Umemura J, Kasanuki H, Ohnishi S, Shoda M, Hosoda S: Recent experience in treating patients with arrhythmogenic right ventricular dysplasia; In Sekiguchi M, Olsen EG, (eds): Cardiomyopathy Update 5: Prognosis and treatment of cardiomyopathies and myocarditis. Japan, Univ Tokyo Press, 1994; p311-321. |
| 196） |
Shiraishi H, Shirayama T, Inoue K, Tanaka H, Kuwabara H, Inoue D, et al: Successful catheter ablation against ventricular tachycardia associated with myotonic dystrophy. Intern Med 2000; 39: 39-44. |
| 197） |
Harada T, Stevenson WG, Kocovic DZ, Friedman PL: Catheter ablation of ventricular tachycardia after myocardial infarction: relation of endocardial sinus rhythm late potentials to the reentry circuit. J Am Coll Cardiol 1997; 30: 1015-1023. |
| 198） |
Aizawa Y, Chinushi M, Naitoh N, Kitazawa H, Washizuka T, Uchiyama H, et al: Catheter ablation of ventricular tachycardia with radiofrequency currents, with special reference to the termination and minor morphologic change of reinduced ventricular tachycardia. Am J Cardiol 1995; 76: 574-579. |
| 199） |
Lundberg A: Paroxysmal tachycardia in infancy: follow-up study of 47 subjects ranging in age from 10 to 26 years. Pediatrics 1973; 51: 26-35. |
| 200） |
Blaufox AD, Felix GL, Saul JP; Pediatric Catheter Ablation Registry: Radiofrequency catheter ablation in infants </=18 months old: when is it done and how do they fare?: short-term data from the pediatric ablation registry. Circulation 2001; 104: 2803-2808. |
| 201） |
Aiyagari R, Saarel EV, Etheridge SP, Bradley DJ, Dick M, Fischbach PS: Radiofrequency ablation for supraventricular tachycardia in children < or =15kg is safe and effective. Pediatr Cardiol 2005; 26: 622-626. |
| 202） |
Joung B, Lee M, Sung JH, Kim JY, Ahn S, Kim S: Pediatric radiofrequency catheter ablation: sedation methods and success, complication and recurrence rates. Circ J 2006; 70: 278-284. |
| 203） |
McDaniel GM, Van Hare GF: Catheter ablation in children and adolescents. Heart Rhythm 2006; 3: 95-101. |
| 204） |
新村一郎，小野ますみ，原口寿夫ほか：WPW症候群小児の経過観察．日小児会誌 1986; 90: 228-236. |
| 205） |
Perry JC, Garson A: Supraventricular tachycardia due to Wolff-Parkinson-White syndrome in children: early disappearance and late recurrence. J Am Coll Cardiol 1990: 16: 1215-1220. |
| 206） |
Mehta AV, Sanchez GR, Sacks EJ, Casta A, Dunn JM, Donner RM: Ectopic automatic atrial tachycardia in children: Clinical characteristics, management and follow-up. J Am Coll Cardiol 1988; 11: 379-385. |
| 207） |
Deal BJ, Keane JF, Gillette PC, Garson A: Wolff-Parkinson-White syndrome and supraventricular tachycardia during infancy: management and follow-up. J Am Coll Cardiol 1985; 5: 130-135. |
| 208） |
北田実男，中島節子，中川 正ほか：基礎心疾患を認めない不整脈患者の長期予後．日小児循環器会誌 1993; 9: 420-430. |
| 209） |
Kugler JD, Danford DA, Houston K, Felix G: Radiofrequency catheter ablation for paroxysmal supraventricular tachycardia in children and adolescents without structural heart disease. Pediatric EP Society, Radiofrequency Catheter Ablation Registry. Am J Cardiol 1997; 80: 1438-1443. |
| 210） |
Kugler JD, Danford DA, Deal BJ, Gillette PC, Perry JC, Silka MJ, et al: Radiofrequency catheter ablation for tachyarrhythmias in children and adolescents. The Pediatric Electrophysiology Society. N Engl J Med 1994; 330: 1481-1487. |
| 211） |
Weber HS, Hellenbrand WE, Kleinman CS, Perlmutter RA, Rosenfeld LE: Predictors of rhythm disturbances and subsequent morbidity after the Fontan operation. Am J Cardiol 1989; 64: 762-767. |
| 212） |
Garson A, Kanter RJ: Management of the child with Wolff-Parkinson-White syndrome and supraventricular tachycardia: model for cost effectiveness. J Cardiovasc Electrophysiol 1997; 8: 1320-1326. |
| 213） |
安井 清，川名伸子，瀧聞浄宏ほか：小児期上室頻拍の予後－カテーテル・アブレーションの適応を考えて－．日小児循環器会誌 1997; 13: 755-761. |
| 214） |
福原仁雄，中村好秀，横山達郎：先天性心疾患症例の頻拍性不整脈に対する高周波カテーテルアブレーション．日小児循環器会誌 1997; 13: 762-772. |
| 215） |
豊原啓子，茶堂 宏，大内秀雄ほか：小児の頻拍性不整脈に対するカテーテル焼灼術．日小児循環器会誌 1998; 14: 510-518. |
| 216） |
Mirowski M, Reid PR, Winkle RA, Mower MM, Watkins L, Stinson EB, et al: Mortality in patients with implanted automatic defibrillators. Ann Intern Med 1983; 98: 585-588. |
| 217） |
Winkle RA, Mead RH, Ruder MA, Gaudiani VA, Smith NA, Buch WS, et al: Long-term outcome with the automatic implantable cardioverter-defibrillator. J Am Coll Cardiol 1989; 13: 1353-1361. |
| 218） |
Zipes DP, Roberts D: Results of the international study of the implantable pacemaker cardioverter-defibrillator. A comparison of epicardial and endocardial lead systems. The Pacemaker-Cardioverter-Defibrillator Investigators. Circulation 1995; 92: 59-65. |
| 219） |
Connolly SJ, Dorian P, Roberts RS, Gent M, Bailin S, Fain ES, et al: Comparison of beta-blockers, amiodarone plus beta-blockers, or sotalol for prevention of shocks from implantable cardioverter defibrillators: the OPTIC Study: a randomized trial. JAMA 2006: 295: 165-171. |
| 220） |
Wilkoff BL, Cook JR, Epstein AE, Greene HL, Hallstrom AP, Hsia H, et al: Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator: the Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial. JAMA 2002; 288: 3115-3123． |
| 221） |
田中茂夫，笠貫 宏，三井利夫：植込み型除細動器の臨床治験に関するガイドライン．心臓ペーシング 1990; 6: 383. |
| 222） |
田中茂夫，早川弘一，安田慶秀，北畠 顕，三井利夫，山口 巌ほか：致死的不整脈に対する植込み型除細動器－Ventak-P1600植込み術の効果と安全性－．心臓ペーシング 1994; 10: 96-108. |
| 223） |
笠貫 宏，細田瑳一，小柳 仁，林 純一，伊藤昭男，早川弘一ほか：心室性不整脈に対する第三世代植込み型除細動器－PCD7217B型の有用性の検討－．心臓ペーシング 1994; 10: 109-123. |
| 224） |
田中茂夫，早川弘一，三井利夫，山口 巌，小柳 仁，細田瑳一ほか：致死的不整脈に対する植込み型除細動器－Ventak-PRX II 植込み型除細動器の効果と安全性－．心臓ペーシング 1997; 13: 16-26. |
| 225） |
笠貫 宏，小柳 仁，北畠 顕，桜井正之，安田慶秀，松居喜郎ほか：心室性頻脈性不整脈に対する第4世代植込み型除細動器－Jewel Plus 7220型の有用性の検討－．心臓ペーシング 1998; 14: 295-308. |
| 226） |
田中茂夫，早川弘一，安田慶秀，松居喜郎，桜井正之，三井利夫ほか：致死的不整脈に対する第4世代植込み型除細動器－Ventak-MINI植込み型除細動器の効果と安全性－．心臓ペーシング 1998; 14: 309-321. |
| 227） |
Mitchell LB: Clinical trials of antiarrhythmic drugs in patients with sustained ventricular tachyarrhythmias. Curr Opin Cardiol 1997; 12: 33-40. |
| 228） |
Wilber DJ, Garan H, Finkelstein D, Kelly E, Newell J, McGovern B, et al: Out-of-hospital cardiac arrest. use of electrophysiologic testing in the prediction of long-term outcome. N Engl J Med 1988; 318: 19-24. |
| 229） |
Kim YH, Sosa-Suarez G, Trouton TG, O'Nunain SS, Osswald S, McGovern BA, et al: Treatment of ventricular tachycardia by transcatheter radiofrequency ablation in patients with ischemic heart disease. Circulation 1994; 89: 1094-1102. |
| 230） |
Gonska BD, Cao K, Schaumann A, Dorszewski A, von zur Mühlen F, Kreuzer H: Catheter ablation of ventricular tachycardia in 136 patients with coronary artery disease: results and long-term follow-up. J Am Coll Cardiol 1994; 24: 1506-1514. |
| 231） |
Strickberger SA, Man KC, Daoud EG, Goyal R, Brinkman K, Hasse C, et al: A prospective evaluation of catheter ablation of ventricular tachycardia as adjuvant therapy in patients with coronary artery disease and an implantable cardioverter-defibrillator. Circulation 1997; 96: 1525-1531. |
| 232） |
Anderson J: Implantable defibrillators are preferable to pharmacologic therapy for patients with ventricular tachyarrhythmias: an antagonist's viewpoint. Prog Cardiovasc Dis 1996; 38: 393-400. |
| 233） |
Saksena S, Madan N, Lewis C: Implanted cardioverte-rdefibrillators are preferable to drugs as primary therapy in sustained ventricular tachyarrhythmias. Prog Cardiovasc Dis 1996; 38: 445-454. |
| 234） |
Kim SG: Evolution of the management of malignant ventricular tachyarrhythmias: the roles of drug therapy and implantable defibrillators. Am Heart J 1995; 130: 1144-1150. |
| 235） |
Böcker D, Block M, Borggrefe M, Breithardt G: Defibrillators are superior to antiarrhythmic drugs in the treatment of ventricular tachyarrhythmias. Eur Heart J 1997; 18: 26-30. |
| 236） |
Zipes DP: Are implantable cardioverter-defibrillators better than conventional antiarrhythmic drugs for survivors of cardiac arrest? Circulation 1995; 91: 2115-2117. |
| 237） |
Sweeney MO, Ruskin JN: Mortality benefits and the implantable cardioverter-defibrillator. Circulation 1994; 89: 1851-1858. |
| 238） |
Cox JL: Patient selection criteria and results of surgery for refractory ischemic ventricular tachycardia. Circulation 1989; 79: I163-77. |
| 239） |
Thomas AC, Moser SA, Smutka ML, Wilson PA: Implantable defibrillation: eight years clinical experience. Pacing Clin Electrophysiol 1988; 11: 2053-2058. |
| 240） |
Fogoros RN, Elson JJ, Bonnet CA, Fiedler SB, Burkholder JA: Efficacy of the automatic implantable cardioverter-defibrillator in prolonging survival in patients with severe underlying cardiac disease. J Am Coll Cardiol 1990; 16: 381-386. |
| 241） |
Powell AC, Fuchs T, Finkelstein DM, Garan H, Cannom DS, McGovern BA, et al: Influence of implantable cardioverter-defibrillators on the long-term prognosis of survivors of out-ofhospital cardiac arrest. Circulation 1993; 88: 1083-1092. |
| 242） |
Wever EF, Hauer RN, van Capelle FL, Tijssen JG, Grijns HJ, Algra A, et al: Randomized study of implantable defibrillator as first-choice therapy versus conventional strategy in postinfarct sudden death survivors. Circulation 1995; 91: 2195-2203. |
| 243） |
Fogoros RN, Fiedler SB, Elson JJ: The automatic implantable cardioverter-defibrillator in drug-refractory ventricular tachyarrhythmias. Ann Intern Med 1987; 107: 635-641. |
| 244） |
Newman D, Sauve MJ, Herre J, Langberg JJ, Lee MA, Titus C, et al: Survival after implantation of the cardioverter defibrillator. Am J Cardiol 1992; 69: 899-903. |
| 245） |
Böcker D, Haverkamp W, Block M, Borggrefe M, Hammel D, Breithardt G: Comparison of d,l-sotalol and implantable defibrillators for treatment of sustained ventricular tachycardia or fibrillation in patients with coronary artery disease. Circulation 1996; 94: 151-157. |
| 246） |
Zipes DP, Wellens HJ: Sudden cardiac death. Circulation 1998; 98: 2334-2351. |
| 247） |
Viskin S, Belhassen B: Polymorphic ventricular tachyarrhythmias in the absence of organic heart disease: classification, differential diagnosis, and implication for therapy. Prog cardiovasc Dis 1998; 41: 17-34. |
| 248） |
Wever EF, Hauer RN, Oomen A, Peters RH, Bakker PF, Robles de Medina EO: Unfavorable outcome in patients with primary electrical disease who survived an episode of ventricular fibrillation. Circulation 1993; 88: 1021-1029. |
| 249） |
Wellens HJ, Lemery R, Smeets JL, Brugada P, Gorgels AP, Cheriex EC, et al: Sudden arrhythmic death without overt heart disease. Circulation 1992; 85(1 Suppl): I 92-97. |
| 250） |
Breithardt G, Wichter T, Haverkamp W, Borggrefe M, Block M, Hammel D, et al: Implantable cardioverter defibrillator therapy in patients with arrhythmogenic right ventricular cardiomyopathy, long QT syndrome, or no structural heart disease. Am Heart J 1994; 127: 1151-1158. |
| 251） |
Pitt B: Sudden cardiac death: role of left ventricular dysfunction. Ann N Y Acad Sci 1982; 382: 218-222. |
| 252） |
Bigger JT: Relation between left ventricular dysfunction and ventricular arrhythmias after myocardial infarction. Am J Cardiol 1986: 57: 8B-14B. |
| 253） |
Holmes J, Kubo SH, Cody RJ, Kligfield P: Arrhythmias in ischemic and nonischemic dilated cardiomyopathy: prediction of mortality by ambulatory electrocardiography. Am J Cardiol 1985; 55: 146-151. |
| 254） |
Bigger JT, Fleiss JL, Kleiger R, Miller JP, Rolnitzky LM: The relationships among ventricular arrhythmias, left ventricular dysfunction, and mortality in the 2 years after myocardial infarction. Circulation 1984; 69: 250-258. |
| 255） |
Buxton AE, Marchlinski FE, Waxman HL, Flores BT, Cassidy DM, Josephson ME: Prognostic factors in nonsustained ventricular tachycardia. Am J Cardiol 1984; 53: 1275-1279. |
| 256） |
Follansbee WP, Michelson EL, Morganroth J: Nonsustained ventricular tachycardia in ambulatory patients: characteristics and association with sudden cardiac death. Ann Intern Med 1980; 92: 741-747. |
| 257） |
Hofmann T, Meinertz T, Kasper W, Geibel A, Zehender M, Hohnloser S, et al: Mode of death in idiopathic dilated cardiomyopathy: a multivariate analysis of prognostic determinants. Am Heart J 1988; 116: 1455-1463. |
| 258） |
Romeo F, Pelliccia F, Cianfrocca C, Cristofani R, Reale A: Predictors of sudden death in idiopathic dilated cardiomyopathy. Am J Cardiol 1989; 63: 138-140. |
| 259） |
Cianfrocca C, Pelliccia F, Nigri A, Critelli G: Resting and ambulatory ECG predictors of mode of death in dilated cardiomyopathy. J Electrocardiol 1992; 25: 295-303. |
| 260） |
Matsuda N, Kasanuki H, Ohnishi S, Hidai C, Horie T, Sekiguchi M, et al: Relationship between ventricular arrhythmias, ventricular dysfunction, and sudden death in dilated cardiomyopathy; In Sekiguchi M, Olsen EG(eds): Cardiomyopathy Update 5: Prognosis and treatment of cardiomyopathies and myocarditis. Japan, Univ Tokyo Press, 1994; p163-168. |
| 261） |
Effect of the antiarrhythmic agent moricizine on survival after myocardial infarction. The Cardiac Arrhythmia Suppression Trial II Investigators. N Engl J Med 1992; 327: 227-233. |
| 262） |
Teo KK, Yusuf S, Furberg CD: Effects of prophylactic antiarrhythmic drug therapy in acute myocardial infarction. An overview of results from randomized controlled trials. JAMA 1993; 270: 1589-1595. |
| 263） |
Burkart F, Pfisterer M, Kiowski W, Follath F, Burckhardt D: Effect of antiarrhythmic therapy on mortality in survivors of myocardial infarction with asymptomatic complex ventricular arrhythmias: Basel Antiarrhythmic Study of Infarct Survival (BASIS). J Am Coll Cardiol 1990; 16: 1711-1718. |
| 264） |
Ceremuzynski L, Kleczar E, Krzeminska-Pakula M, Kuch J, Nartowicz E, Smielak-Korombel J, et al : Effect of amiodarone on mortality after myocardial infarction: a double-blind, placebo-controlled, pilot study. J Am Coll Cardiol 1992; 20: 1056-1062. |
| 265） |
Cairns JA, Connolly SJ, Roberts R, Gent M: Randomised trial of outcome after myocardial infarction in patients with frequent or repetitive ventricular premature depolarisations: CAMIAT. Canadian Amiodarone Myocardial Infarction Arrhythmia Trial Investigators. Lancet 1997; 349: 675-682. |
| 266） |
Singh SN, Fletcher RD, Fisher SG, Singh BN, Lewis HD, Deedwania PC: Amiodarone in patients with congestive heart failure and asymptomatic ventricular arrhythmia. Survival Trial of Antiarrhythmic Therapy in Congestive Heart Failure. N Engl J Med 1995; 333: 77-82. |
| 267） |
Effect of prophylactic amiodarone on mortality after acute myocardial infarction and in congestive heart failure: meta-analysis of individual data from 6500 patients in randomised trials. Amiodarone Trials Meta-Analysis Investigators. Lancet 1997; 350: 1417-1424. |
| 268） |
Sim I, McDonald KM, Lavori PW, Narbutas CM, Hlatky MA: Quantitative overview of randomized trials of amiodarone to prevent sudden cardiac death. Circulation 1997; 96: 2823-2829. |
| 269） |
Wilber DJ, Olshansky B, Moran JF, Scanlon PJ: Electrophysiological testing and nonsustained ventricular tachycardia. use and limitations in patients with coronary artery disease and impaired ventricular function. Circulation 1990; 82: 350-358. |
| 270） |
Moss AJ, Hall WJ, Cannom DS, Daubert JP, Higgins SL, Klein H: Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. Multicenter Automatic Defibrillator Implantation Trial Investigators. N Engl J Med 1996; 335: 1933-1940. |
| 271） |
Buxton AE, Lee KL, Fisher JD, Josephson ME, Prystowsky EN, Hafley G: A randomized study of the prevention of sudden death in patients with coronary artery disease. Multicenter Unsustained Tachycardia Trial Investigators. N Engl J Med 1999; 341: 1882-1890. |
| 272） |
Moss AJ, Zareba W, Hall WJ, Klein H, Wilber DJ, Cannom DS, et al: Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med 2002; 346: 877-883. |
| 273） |
Bardy GH, Lee KL, Mark DB, Poole JE, Packer DL, Boineau R, et al: Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med 2005; 352: 225-237. |
| 274） |
Kawashiro N, Matsuda N, Haze K, Honda T, Horie T, et al: Sudden cardiac death in Japanese heart failure: results from a multicenter retrospective cohort study. Circulation J 2006; 70suppl: 40. |
| 275） |
Fananapazir L, Epstein SE: Hemodynamic and electrophysiologic evaluation of patients with hypertrophic cardiomyopathy surviving cardiac arrest. Am J Cardiol 1991; 67: 280-287. |
| 276） |
Zhu DW, Sun H, Hill R, Roberts R: The value of electrophysiology study and prophylactic implantation of cardioverter defibrillator in patients with hypertrophic cardiomyopathy. Pacing Clin Electrophysiol 1998; 21: 299-302. |
| 277） |
Krol RB, Morady F, Flaker GC, DiCarlo LA, Baerman JM, Hewett J, et al: Electrophysiologic testing in patients with unexplained syncope: clinical and noninvasive predictors of outcome. J Am Coll Cardiol 1987; 10: 358-363. |
| 278） |
DiMarco JP, Garan H, Harthorne JW, Ruskin JN: Intracardiac electrophysiologic techniques in recurrent syncope of unknown case. Ann Intern Med 1981; 95: 542-548. |
| 279） |
Akhtar M, Shenasa M, Denker S, Gilbert CJ, Rizwi N: Role of cardiac electrophysiologic studies in patients with unexplained recurrent syncope. Pacing Clin Electrophysiol 1983; 6: 192-201. |
| 280） |
Bass EB, Elson JJ, Fogoros RN, Peterson J, Arena VC, Kapool WN: Long-term prognosis of patients undergoing electrophysiologic studies for syncope of unknown origin. Am J Cardiol 1988; 62: 1186-1191. |
| 281） |
Bachinsky WB, Linzer M, Weld L, Estes NA: Usefulness of clinical characteristics in predicting the outcome of electrophysiologic studies in unexplained syncope. Am J Cardiol 1992; 69: 1044-1049. |
| 282） |
Olshansky B, Hahn EA, Hartz VL, Prater SP, Mason JW: Clinical significance of syncope in the electrophysiologic study versus electrocardiographic monitoring (ESVEM) trial. The ESVEM Investigators. Am Heart J 1999; 137: 878-886. |
| 283） |
Akhtar M, Garan H, Lehmann MH, Troup PJ: Sudden cardiac death: management of high-risk patients. Ann Intern Med 1991; 114: 499-512. |
| 284） |
Mittal S, Iwai S, Stein KM, Markowitz SM, Slotwiner DJ, Lerman BB: Long-term outcome of patients with unexplained syncope treated with an electrophysiologic-guided approach in the implantable cardioverter-defibrillator era. J Am Coll Cardiol 1999; 34: 1082-1089. |
| 285） |
Link MS, Costeas XF, Griffith JL, Colburn CD, Estes NA, Wang PJ: High incidence of appropriate implantable cardioverter-defibrillator therapy in patients with syncope of unknown etiology and inducible ventricular arrhythmias. J Am Coll Cardiol 1997; 29: 370-375. |
| 286） |
Militianu A, Salacata A, Seibert K, Kehoe R, Baga JJ, Meissner MD, et al: Implantable cardioverter defibrillator utilization among device recipients presenting exclusively with syncope or near-syncope. J Cardiovasc Electrophysiol 1997; 8: 1087-1097. |
| 287） |
Saksena S, Breithardt G, Dorian P, Greene HL, Madan N, Block M: Nonpharmacological therapy for malignant ventricular arrhythmias: implantable defibrillator trials. Prog Cardiovasc Dis 1996; 38: 429-444. |
| 288） |
Nisam S, Kaye SA, Mower MM, Hull M: AICD automatic cardioverter defibrillator clinical update: 14 years experience in over 34,000 patients. Pacing Clin Electrophysiol 1995; 18: 142-147. |
| 289） |
Axtell K, Tchou P, Akhtar M: Survival in patients with depressed left ventricular function treated by implantable cardioverter defibrillator. Pacing Clin Electrophysiol 1991; 14: 291-296. |
| 290） |
Wever EF, Hauer RN, Schrijvers G, van Capelle FJ, Tijssen JG, Crijns HJ, et al: Cost-effectiveness of implantable defibrillator as first-choice therapy versus electrophysiologically guided, tiered strategy in postinfarct sudden death survivors. A randomized study. Circulation 1996; 93: 489-496. |
| 291） |
Hook BG, Marchlinski FE: Value of ventricular electrogram recordings in the diagnosis of arrhythmias precipitating electrical device shock therapy. J Am Coll Cardiol 1991; 17: 985-990. |
| 292） |
Leitch JW, Gillis AM, Wyse DG, Yee R, Klein GJ, Guiraudon G, et al: Reduction in defibrillator shocks with an implantable device combining antitachycardia pacing and shock therapy. J Am Coll Cardiol 1991; 18: 145-151. |
| 293） |
Andrews NP, Fogel RI, Pelargonio G, Evans JJ, Prystowsky EN: Implantable defibrillator event rates in patients with unexplained syncope and inducible sustained ventricular tachyarrhythmias: a comparison with patients known to have sustained ventricular tachycardia. J Am Coll Cardiol 1999; 34: 2023-2030. |
| 294） |
Middlekauff HR, Stevenson WG, Stevenson LW, Saxon LA: Syncope in advanced heart failure: high risk of sudden death regardless of origin of syncope. J Am Coll Cardiol 1993; 21: 110-116. |
| 295） |
Fruhwald FM, Eber B, Schumacher M, Zweiker R, Watzinger N, Klein WW: Syncope in dilated cardiomyopathy is a predictor of sudden cardiac death. Cardiology 1996; 87: 177-180. |
| 296） |
Grimm W, Hoffmann J, Menz V, Luck K, Maisch B: Programmed ventricular stimulation for arrhythmia risk prediction in patients with idiopathic dilated cardiomyopathy and nonsustained ventricular tachycardia.J Am Coll Cardiol 1998; 32: 739-745. |
| 297） |
Knight BP, Goyal R, Pelosi F, Flemming M, Horwood L, Morady F, et al: Outcome of patients with nonischemic dilated cardiomyopathy and unexplained syncope treated with an implantable defibrillator. J Am Coll Cardiol 1999; 33: 1964-1970. |
| 298） |
Brugada P, Brugada J: Right bundle branch block, persistent ST segment elevation and sudden cardiac death: a distinct clinical and electrocardiographic syndrome. A multicenter report. J Am Coll Cardiol 1992; 20: 1391-1396. |
| 299） |
Kasanuki H, Ohnishi S, Ohtuka M, Matsuda N, Nirei T, Isogai R, et al: Idiopathic ventricular fibrillation induced with vagal activity in patients without obvious heart disease. Circulation 1997; 95: 2277-2285. |
| 300） |
Miyazaki T, Mitamura H, Miyoshi S, Soejima K, Aizawa Y, Ogawa S: Autonomic and antiarrhythmic drug modulation of ST segment elevation in patients with Brugada syndrome. J Am Coll Cardiol 1996; 27: 1061-1070. |
| 301） |
Wilde AA, Antzelevitch C, Borggrefe M, Brugada J, Brugada R, Brugada P, et al: Proposed diagnostic criteria for the Brugada syndrome: consensus report. Circulation 2002; 106: 2514-2519. |
| 302） |
Brugada J, Brugada P: Further characterization of the syndrome of right bundle branch block, ST segment elevation, and sudden cardiac death. J Cardiovasc Electrophysiol 1997; 8: 325-331. |
| 303） |
Chen Q, Kirsch GE, Zhang D, Brugada R, Brugada J, Brugada P, et al: Genetic basis and molecular mechanism for idiopathic ventricular fibrillation. Nature 1998; 392: 293-296. |
| 304） |
Brugada J, Brugada R, Brugada P: Right bundle-branch block and ST-segment elevation in leads V1 through V3: a marker for sudden death in patients without demonstrable structural heart disease. Circulation 1998; 97: 457-460. |
| 305） |
Nademanee K, Veerakul G, Nimmannit S, Chaowakul V, Bhuripanyo K, Likittanasombat K, et al: Arrhythmogenic marker for the sudden unexplained death syndrome in Thai men. Circulation 1997; 96: 2595-2600. |
| 306） |
Atarashi H, Ogawa S, Harumi K, Sugimoto T, Inoue H, Murayama M, et al: Three-year follow-up of patients with right bundle branch block and ST segment elevation in the right precordial leads: Japanese Registry of Brugada Syndrome. Idiopathic Ventricular Fibrillation Investigators. J Am Coll Cardiol 2001; 37: 1916-1920. |
| 307） |
Brugada P, Brugada R, Brugada J, Geelen P: Use of the prophylactic implantable cardioverter defibrillator for patients with normal hearts. Am J Cardiol 1999; 83(5B): 98D-100D. |
| 308） |
Gussak I, Antzelevitch C, Bjerregaard P, Towbin JA, Chaitman BR: The Brugada syndrome: clinical, electrophysiologic and genetic aspects. J Am Coll Cardiol 1999; 33: 5-15. |
| 309） |
Antzelevitch C, Brugada P, Borggrefe M, Brugada J, Brugada R, Corrado D, et al: Brugada syndrome: report of the second consensus conference: endorsed by the Heart Rhythm Society and the European Heart Rhythm Association. Circulation 2005; 111: 659-670. |
| 310） |
Garson A, Dick M, Fournier A, Gillette PC, Hamilton R, Kugler JD, et al: The long QT syndrome in children. An international study of 287 patients. Circulation 1993; 87: 1866-1872. |
| 311） |
Moss AJ, Schwartz PJ, Crampton RS, Locati E, Carleen E: The long QT syndrome: a prospective international study. Circulation 1985; 71: 17-21. |
| 312） |
Moss AJ, Schwartz PJ, Crampton RS, Tzivoni D, Locati EH, MacCluer J, et al: The long QT syndrome: Prospective longitudinal study of 328 families. Circulation 1991; 84: 1136-1144. |
| 313） |
Silka MJ, Kron J, Dunnigan A, Dick M: Sudden cardiac death and the use of implantable cardioverter-defibrillators in pediatric patients. The Pediatric Electrophysiology Society. Circulation 1993; 87: 800-807. |
| 314） |
Groh WJ, Silka MJ, Oliver RP, Halperin BD, McAnulty JH, Kron J: Use of implantable cardioverter-defibrillators in the congenital long QT syndrome. Am J Cardiol 1996; 78: 703-706. |
| 315） |
Moss AJ: Management of patients with the hereditary long QT syndrome. J Cardiovasc Electrophysiol 1998; 9: 668-674. |
| 316） |
Schwartz PJ: The long QT syndrome. Curr Probl Cardiol
1997; 22: 297-351. |
| 317） |
Fenelon G, Huvelle E, Brugada P: Initial clinical experience with a new small sized third-generation implantable cardioverter defibrillator: results of a multicenter study. European Ventak Mini Investigator Group. Pacing Clin Electrophysiol 1997; 20: 2967-2974. |
| 318） |
Klein H, Auricchio A, Huvelle E, Nisam S: Initial clinical experience with a new down-sized implantable cardioverter-defibrillator. Am J Cardiol 1996; 78 (5A): 9-14. |
| 319） |
Kron J, Silka MJ, Ohm OJ, Bardy G, Benditt D: Preliminary experience with nonthoracotomy implantable cardioverter defibrillators in young patients. The Medtronic Transvene Investigators. Pacing Clin Electrophysiol 1994; 17: 26-30. |
| 320） |
Kron J, Oliver RP, Norsted S, Silka MJ: The automatic implantable cardioverter-defibrillator in young patients. J Am Coll Cardiol 1990; 16: 896-902. |
| 321） |
Wilson WR, Greer GE, Grubb BP: Implantable cardioverter-defibrillators in children: a single-institutional experience. Ann Thorac Surg 1998; 65: 775-778. |
| 322） |
Silka MJ, Halperin BD, Kron J: The use of implantable cardioverter-defibrillators in children. Cardiol Rev 1996; 4: 93-100. |
| 323） |
Elliott PM, Sharma S, Varnava A, Poloniecki J, Rowland E, McKenna WJ: Survival after cardiac arrest or sustained ventricular tachycardia in patients with hypertrophic cardiomyopathy. J Am Coll Cardiol 1999; 33: 1596-1601. |
| 324） |
Hamilton RM, Dorian P, Gow RM, Williams WG: Five-year experience with implantable defibrillators in children. Am J Cardiol 1996; 77: 524-526. |
| 325） |
Kaminer SJ, Pickoff AS, Dunnigan A, Sterba R, Wolff GS: Cardiomyopathy and the use of implanted cardio-defibrillators in children. Pacing Clin Electrophysiol 1990; 13: 593-597. |
| 326） |
Sumitomo N, Harada K, Nagashima M, Yasuda T, Nakamura Y, Aragaki Y, et al: Catecholaminergic polymorphic ventricular tachycardia: electrocardiographic characteristics and optimal therapeutic strategies to prevent sudden death. Heart 2003; 89: 66-70. |
| 327） |
Abraham WT, Fisher WG, Smith AL, Delurgio DB, Leon AR, Loh E, et al: Cardiac resynchronization in chronic heart failure. N Engl J Med 2002; 346: 1845-1853. |
| 328） |
Cleland JG, Daubert JC, Erdmann E, Freemantle N, Gras D, Kappenberger L, et al: The effect of cardiac resynchronization on morbidity and mortality in heart failure. N Engl J Med 2005; 352: 1539-1549. |
| 329） |
Cazeau S, Leclercq C, Lavergne T, Walker S, Varma C, Linde C, et al: Effects of multisite biventricular pacing in patients with heart failure and intraventricular conduction delay: N Engl J Med 2001; 344: 873-880． |
| 330） |
Bristow MR, Saxon LA, Boehmer J, Krueger S, Kass DA, De Marco T, et al.: Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. N Engl J Med. 2004; 350: 2140-2150. |
| 331） |
Couch OA: Cardiac aneurysm with ventricular tachycardia and subsequent excision of aneurysm; case report. Circulation 1959; 20: 251-253. |
| 332） |
Cobb FR, Blumenschein SD, Sealy WC, Boineau JP, Wagner GS, Wallace AG: Successful surgical interruption of the bundle of Kent in a patient with Wolff-Parkinson-White syndrome. Circulation 1968; 38: 1018-1029. |
| 333） |
Iwa T, Mitsui T, Misaki T, Mukai K, Magara T, Kamata E: Radical surgical cure of Wolff-Parkinson-White syndrome: the Kanazawa experience. J Thorac Cardiovasc Surg 1986; 91: 225-233. |
| 334） |
Guiraudon G, Fontaine G, Frank R, Escande G, Etievent P, Cabrol C: Encircling endocardial ventriculotomy: a new surgical treatment for life-threatening ventricular tachycardias resistant to medical treatment following myocardial infarction. Ann Thorac Surg 1978; 26: 438-444. |
| 335） |
Cox JL, Schuessler RB, Boineau JP: The surgical treatment of atrial fibrillation: I. Summary of the current concepts of the mechanisms of atrial flutter and atrial fibrillation. J Thorac Cardiovasc Surg 1991; 101: 402-405. |
| 336） |
Cox JL, Schuessler RB, D'Agostino HJ, Stone CM, Chang BC, Cain ME, et al: The surgical treatment of atrial fibrillation. III. Development of a definitive surgical procedure. J Thorac Cardiovasc Surg 1991; 101: 569-583. |
| 337） |
Dor V, Sabatier M, Montiglio F, Rossi P, Toso A, Di Donato M: Results of nonguided subtotal endocardiectomy associated with left ventricular reconstruction in patients with ischemic ventricular arrhythmias. J Thorac Cardiovasc Surg 1994; 107: 1301-1308. |
| 338） |
Kobayashi J, Yamamoto F, Nakano K, Sasako Y, Kitamura S, Kosakai Y: Maze procedure for atrial fibrillation associated with atrial septal defect. Circulation 1998; 98(19 Suppl): II 399-402. |
| 339） |
Isobe F, Kawashima Y: The outcome and indications of the Cox maze III procedure for chronic atrial fibrillation with mitral valve disease. J Thorac Cardiovasc Surg 1998; 116: 220-227. |
| 340） |
Cox JL, Ad N, Palazzo T: Impact of the maze procedure on the stroke rate in patients with atrial fibrillation. J Thorac Cardiovasc Surg 1999; 118: 833-840. |
| 341） |
Jessurun ER, van Hemel NM, Defauw JA, Stofmeel MA, Kelder JC, de la Rivière AB, et al: Results of maze surgery for lone paroxysmal atrial fibrillation. Circulation 2000; 101: 1559-1567. |
| 342） |
Lönnerholm S, Blomström P, Nilsson L, Oxelbark S, Jideus L, Blomström-Lundqvist C: Effects of the maze operation on health-related quality of life in patients with atrial fibrillation. Circulation 2000; 101: 2607-2611. |
| 343） |
Kosakai Y, Kawaguchi AT, Isobe F, Sasako Y, Nakano K, Eishi K, et al: Modified maze procedure for patients with atrial fibrillation undergoing simultaneous open heart sugery. Circulation 1995; 92(9 Suppl): II 359-364. |
| 344） |
Sueda T, Nagata H, Orihashi K, Morita S, Okada K, Sueshiro M, et al: Efficacy of a simple left atrial procedure for chronic atrial fibrillation in mitral valve operations. Ann Thorac Surg 1997; 63: 1070-1075. |
| 345） |
Nitta T, Lee R, Schuessler RB, Boineau JP, Cox JL: Radial approach: a new concept in surgical treatment for atrial fibrillation I. Concept, anatomic and physiologic bases and development of a procedure. Ann Thorac Surg 1999; 67: 27-35. |
| 346） |
Gaynor SL, Diodato MD, Prasad SM, Ishii Y, Schuessler RB, Bailey MS, et al: A prospective, single-center clinical trial of a modified Cox maze procedure with bipolar radiofrequency ablation. J Thorac Cardiovasc Surg 2004; 128: 535-542. |
| 347） |
Wolf RK, Schneeberger EW, Osterday R, Miller D, Merrill W, Flege JB, et al: Video-assisted bilateral pulmonary vein isolation and left atrial appendage exclusion for atrial fibrillation. J Thorac Cardiovasc Surg 2005; 130: 797-802. |
| 348） |
Bando K, Kobayashi J, Kosakai Y, Hirata M, Sasako Y, Nakatani S, et al: Impact of Cox maze procedure on outcome in patients with atrial fibrillation and mitral valve disease. J Thorac Cardiovasc Surg 2002; 124: 575-583. |
| 349） |
Bando K, Kasegawa H, Okada Y, Kobayashi J, Kada A, Shimokawa T, et al: Impact of preoperative and postoperative atrial fibrillation on outcome after mitral valvuloplasty for nonischemic mitral regurgitation. J Thorac Cardiovasc Surg 2005; 129: 1032-1040. |
| 350） |
Damiano RJ, Gaynor SL, Bailey M, Prasad S, Cox JL, Boineau JP, et al: The long-term outcome of patients with coronary disease and atrial fibrillation undergoing the Cox maze procedure. J Thorac Cardiovasc Surg 2003; 126: 2016-2021. |
| 351） |
Prasad SM, Maniar HS, Camillo CJ, Schuessler RB, Boineau JP, Sundt TM, et al: The Cox maze III procedure for atrial fibrillation: long-term efficacy in patients undergoing lone versus concomitant procedures. J Thorac Cardiovasc Surg 2003; 126: 1822-1828. |
| 352） |
Nitta T, Ishii Y, Miyagi Y, Ohmori H, Sakamoto S, Tanaka S: Concurrent multiple left atrial focal activations with fibrillatory conduction and right atrial focal or reentrant activation as the mechanism in atrial fibrillation. J Thorac Cardiovasc Surg 2004; 127: 770-778. |
| 353） |
Nitta T, Ohmori H, Sakamoto S, Miyagi Y, Kanno S, Shimizu K: Map-guided surgery for atrial fibrillation. J Thorac Cardiovasc Surg 2005; 129: 291-299. |
| 354） |
Kanter RJ, Garson A: Atrial arrhythmias during chronic follow-up of surgery for complex congenital heart disease. Pacing Clin Electrophysiol 1997; 20: 502-511. |
| 355） |
Triedman JK, Jenkins KJ, Colan SD, Saul JP, Walsh EP: Intra-atrial reentrant tachycardia after palliation of congenital heart disease: characterization of multiple macroreentrant circuits using fluoroscopically based three-dimensional endocardial mapping. J Cardiovasc Electrophysiol 1997; 8: 259-270. |
| 356） |
Chan DP, Van Hare GF, Mackall JA, Carlson MD, Waldo AL: Importance of atrial flutter isthmus in postoperative intra-atrial reentrant tachycardia. Circulation 2000; 102: 1283-1289. |
| 357） |
Nakagawa H, Shah N, Matsudaira K, Overholt E, Chandrasekaran K, Beckman KJ, et al: Characterization of reentrant circuit in macroreentrant right atrial tachycardia after surgical repair of congenital heart disease: isolated channels between scars allow "focal" ablation. Circulation 2001; 103: 699-709. |
| 358） |
Akar JG, Kok LC, Haines DE, DiMarco JP, Mounsey JP: Coexistence of type I atrial flutter and intra-atrial re-entrant tachycardia in patients with surgically corrected congenital heart disease. J Am Coll Cardiol 2001; 38: 377-384. |
| 359） |
Balaji S, Gewillig M, Bull C, de Leval MR, Deanfield JE: Arrhythmias after the Fontan procedure. Comparison of total cavopulmonary connection and atriopulmonary connection. Circulation 1991; 84(5 Suppl): III 162-167. |
| 360） |
Gelatt M, Hamilton RM, McCrindle BW, Connelly M, Davis A, Harris L, et al: Arrhythmia and mortality after the Mustard procedure: a 30-year single-center experience. J Am Coll Cardiol 1997; 29: 194-201. |
| 361） |
Lesh MD, Kalman JM, Saxon LA, Dorostkar PC: Electrophysiology of "incisional" reentrant atrial tachycardia complicating surgery for congenital heart disease. Pacing Clin Electrophysiol 1997; 20: 2107-2111. |
| 362） |
Lukac P, Pedersen AK, Mortensen PT, Jensen HK, Hjortdal V, Hansen PS: Ablation of atrial tachycardia after surgery for congenital and acquired heart disease using an electroanatomic mapping system: Which circuits to expect in which substrate? Heart Rhythm 2005; 2: 64-72. |
| 363） |
Mavroudis C, Backer CL, Deal BJ, Johnsrude CL: Fontan conversion to cavopulmonary connection and arrhythmia circuit cryoblation. J Thorac Cardiovasc Surg 1998; 115: 547-556. |
| 364） |
Mavroudis C, Backer CL, Deal BJ, Johnsrude C, Strasburger J: Total cavopulmonary conversion and maze procedure for patients with failure of the Fontan operation. J Thorac Cardiovasc Surg 2001; 122: 863-871. |
| 365） |
Deal BJ, Mavroudis C, Backer CL: Beyond Fontan conversion: Surgical therapy of arrhythmias including patients with associated complex congenital heart disease. Ann Thorac Surg 2003; 76: 542-554. |
| 366） |
Misaki T, Watanabe G, Iwa T, Watanabe Y, Mukai K, Takahashi M, et al: Surgical treatment of patients with Wolff-Parkinson-White syndrome and associated Ebstein's anomaly. J Thorac Cardiovasc Surg 1995; 110: 1702-1707. |
| 367） |
Josephson ME: Treatment of ventricular arrhythmias after myocardial infarction. Circulation 1986; 74: 653-658. |
| 368） |
Swerdlow CD, Mason JW, Stinson EB, Oyer PE, Winkle RA, Derby GC: Results of operations for ventricular tachycardia in 105 patients. J Thorac Cardiovasc Surg 1986; 92: 105-113. |
| 369） |
Littmann L, Svenson RH, Gallagher JJ, Selle JG, Zimmern SH, Fedor JM, et al: Functional role of the epicardium in postinfarction ventricular tachycardia. Observations derived from computerized epicardial activation mapping, entrainment, and epicardial laser photoablation. Circulation 1991; 83: 1577-1591. |
| 370） |
Stevenson WG, Friedman PL, Kocovic D, Sager PT, Saxon LA, Pavri B: Radiofrequency catheter ablation of ventricular tachycardia after myocardial infarction. Circulation 1998; 98: 308-314. |
| 371） |
Downar E, Kimber S, Harris L, Mickleborough L, Sevaptsidis E, Masse S, et al: Endocardial mapping of ventricular tachycardia in the intact human heart. II. Evidence for multiuse reentry in a functional sheet of surviving myocardium. J Am Coll Cardiol 1992; 20: 869-878. |
| 372） |
Rastegar H, Link MS, Foote CB, Wang PJ, Manolis AS, Estes NA: Perioperative and long-term results with mapping-guided subendocardial resection and left ventricular endoaneurysmorrhaphy. Circulation 1996; 94: 1041-1048. |
新検索ページはこちら
ログイン
お問い合わせ
書誌情報
